ArticleThe oncologist2016

A Phase I Study of the Safety and Pharmacokinetics of Higher-Dose Icotinib in Patients With Advanced Non-Small Cell Lung Cancer.

Jian Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.